Default company panoramic image
Moleculera logo cmyk

Moleculera Labs, Inc.

Autoimmune Neurobiology Company with a unique business model that generates CLIA revenue while identifing both diagnostic and therapeutic CNS disorder targets

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location Oklahoma City, OK, USA
  • Currency USD
  • Founded September 2011
  • Employees 15
  • Website moleculera.com

Company Summary

Over 60 million Americans suffer from neurologic and mental disorders who are treated with neuropsychiatric drugs, yet their condition persists, often with little improvement. Our unique business model generates CLIA lab revenue, thousands of well-annotated and informed consented clinical specimens, and dozens of collaborators as we identify both diagnostic and therapeutic immune-mediated CNS disorder targets, with demonstrated clinical studies.

Team

  • Default avatar
    Craig Shimasaki, PhD, MBA
    President & CEO

  • Default avatar
    Madeleine Cunningham, PhD
    Chief Scientific Officer

  • Default avatar
    Fred Hiller
    CFO

  • Craig 20 2
    President & CEO

Advisors

Previous Investors

  • Default avatar
    Innovation to Enterprise (i2E)
    Unconfirmed
    Default avatar
    SeedStep Angels and Local Investors
    Unconfirmed
    Default avatar
    Dr. Brian Clevinger, Prolog Ventures
    Managing Director
    Unconfirmed